Titlebook: Idiopathic Pulmonary Fibrosis; Advances in Diagnost Hiroyuki Nakamura,Kazutetsu Aoshiba Book 2016 Springer Japan 2016 HRCT.IIP.IPF.KL-6.SP-

內(nèi)行

燈絲

urce for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop 978-4-431-56281-8978-4-431-55582-7

怕失去錢(qián)

Hiroyuki Nakamura,Kazutetsu AoshibaIntroducing new developments such as serum makers that are highly specific to IPF, the establishment of systematic diagnosis imaging and antifibrotic agent.Each chapter addresses key issues under disc

浪費(fèi)物質(zhì)

Absenteeism

EVEN

發(fā)起

Epidemiology and Risk Factors of IPFfibrosis (IPF) is worse than any form of other IIPs, because there are few effective treatments clinically approved. Although many risk factors are recognized, the etiologies of fibrotic lung diseases are not clear. Genetic background and environmental factors are thought to be involved in the etiol

Mets552

NAV

項(xiàng)目